Free Membership
Newsletter
Help
Subscribe
Sign In
Search
January 27, 2023
All times are Vienna time
Search
Subscribe
Sign In
Countries:
Africa »
Algeria Angola Benin Botswana Burundi Côte d'Ivoire Ethiopia Ghana Guinea Kenya Lesotho Liberia Libya Mali Mauritius Morocco Mozambique Namibia Niger Nigeria Rwanda South Africa Sudan Tanzania The Congo Togo Tunisia Uganda Zambia Zimbabwe
Asia-Pacific »
Afghanistan Australia Bangladesh Cambodia China Hong Kong SAR India Indonesia Japan Laos Malaysia Mongolia Myanmar Nepal New Zealand North Korea (DPRK) Pakistan Philippines Singapore South Korea Sri Lanka Taiwan Thailand Vietnam
Central- & Eastern Europe »
Albania Bosnia & Herzegovina Bulgaria Croatia Czech Rep. Estonia Georgia Hungary Kosovo Latvia Lithuania North Macedonia Montenegro Poland Romania Serbia Slovakia Slovenia Ukraine Western Balkans
Middle East »
Egypt Iran Iraq Israel Jordan Kuwait Lebanon Oman Palestinian Territories Qatar Saudi Arabia Syria Turkey United Arab Emirates Yemen
Russia & CIS »
Russia Armenia Azerbaijan Belarus Kazakhstan Kyrgyzstan Moldova Turkmenistan Uzbekistan
The Americas »
Argentina Bolivia Brazil Canada Central America Chile Colombia Cuba Ecuador Mexico Panama Paraguay Peru The Caribbean Uruguay Venezuela
United States
Western Europe »
Belgium Cyprus Denmark Finland France Germany Greece Iceland Ireland Italy Liechtenstein Luxembourg Malta Monaco Norway Portugal Scotland Spain Sweden Switzerland The Netherlands United Kingdom Vatican City
Business:
Economy
Economic Policies
Investing in Austria
Securities
Earnings
Foreign Trade
Deals
Legal Issues
More Business & Economics+
Politics:
Domestic
Brussels
International
Diplomacy
Companies:
Professional Services »
Banks Financial Services Real Estate Insurance Other Services
Energy »
Oil & Gas Utilities Renewables Mining
Industrials »
Construction Automotive Industrial Goods Basic Resources Chemicals Other Industrials
Transport »
Airlines & Airports Shipping Rail Road
Retail & Consumer
Health Care
Technology
Telecoms
Media
Tourism
Other
Organizations:
Diplomatic Missions
International Organizations
Other
People:
Executives
Politicians
Diplomats
Entrepreneurs
Other
Lifestyle & Travel:
Culture
Travel
Personal Real Estate
Health
Food & Drink
Luxury Goods
More+
More+:
Events
Photo Galleries
Videos
Classifieds
Work & Careers
More+
Home
Countries
Business
Politics
Diplomacy
Companies
Organizations
People
Lifestyle & Travel
More+
Africa
Algeria
Angola
Benin
Botswana
Burundi
Côte d'Ivoire
Ethiopia
Ghana
Guinea
Kenya
Lesotho
Liberia
Libya
Mali
Mauritius
Morocco
Mozambique
Namibia
Niger
Nigeria
Rwanda
South Africa
Sudan
Tanzania
The Congo
Togo
Tunisia
Uganda
Zambia
Zimbabwe
Asia-Pacific
Afghanistan
Australia
Bangladesh
Cambodia
China
Hong Kong SAR
India
Indonesia
Japan
Laos
Malaysia
Mongolia
Myanmar
Nepal
New Zealand
North Korea (DPRK)
Pakistan
Philippines
Singapore
South Korea
Sri Lanka
Taiwan
Thailand
Vietnam
Central- & Eastern Europe
Albania
Bosnia & Herzegovina
Bulgaria
Croatia
Czech Rep.
Estonia
Georgia
Hungary
Kosovo
Latvia
Lithuania
North Macedonia
Montenegro
Poland
Romania
Serbia
Slovakia
Slovenia
Ukraine
Western Balkans
Middle East
Egypt
Iran
Iraq
Israel
Jordan
Kuwait
Lebanon
Oman
Palestinian Territories
Qatar
Saudi Arabia
Syria
Turkey
United Arab Emirates
Yemen
Russia & CIS
Russia
Armenia
Azerbaijan
Belarus
Kazakhstan
Kyrgyzstan
Moldova
Turkmenistan
Uzbekistan
The Americas
Argentina
Bolivia
Brazil
Canada
Central America
Chile
Colombia
Cuba
Ecuador
Mexico
Panama
Paraguay
Peru
The Caribbean
Uruguay
Venezuela
United States
Western Europe
Belgium
Cyprus
Denmark
Finland
France
Germany
Greece
Iceland
Ireland
Italy
Liechtenstein
Luxembourg
Malta
Monaco
Norway
Portugal
Scotland
Spain
Sweden
Switzerland
The Netherlands
United Kingdom
Vatican City
Economy
Economic Policies
Investing in Austria
Securities
Earnings
Foreign Trade
Deals
Legal Issues
More Business & Economics+
Domestic
Brussels
International
Professional Services
Banks
Financial Services
Real Estate
Insurance
Other Services
Energy
Oil & Gas
Utilities
Renewables
Mining
Industrials
Construction
Automotive
Industrial Goods
Basic Resources
Chemicals
Other Industrials
Transport
Airlines & Airports
Shipping
Rail
Road
Retail & Consumer
Health Care
Technology
Telecoms
Media
Tourism
Other
Diplomatic Missions
International Organizations
Other
Executives
Politicians
Diplomats
Entrepreneurs
Other
Culture
Travel
Personal Real Estate
Health
Food & Drink
Luxury Goods
More+
Events
Photo Galleries
Videos
Classifieds
Work & Careers
More+
Latest News
Ukrainian War
Covid in Austria
USA in Vienna
UK in Vienna
Russia in Vienna
China in Vienna
Iran in Vienna
UN
OSCE
IAEA
OPEC
Sponsored Content
apple banana find news that contain at least one of the two words.
"some words" find news that contain the exact phrase "some words".
apple* find news that contain words such as "apple", "apples", "applesauce", or "applet".
+apple +juice find news that contain both words.
+apple -macintosh find news that contain the word "apple" but not "macintosh".
+apple macintosh find news that contain "apple", but rank news higher if they also contain "macintosh".
(click to close)

Intercell

Sponsored Content

Valneva Completes EUR 45 Million Capital Increase

The listed biotechnology company Valneva SE announces the completion of its capital increase with shareholders preferential subscription rights launched on January 12th, 2015. Valneva estimates net proceeds of EUR 42 millions from 18.2 million offered new shares. The new ordinary shares will be traded on Euronext and on the Prime Market segment of the Vienna Stock Exchange. The financing will mainly be used for the acquisition of Crucell Sweden AB and all assets, licenses and privileges related to Dukoral.

February 4, 2015
Sponsored Content

Intercell Announces Pediatric Approval of its Japanese Encephalitis Vaccine in the U.S.

Intercell Announces Pediatric Approval of its Japanese Encephalitis Vaccine in the U.S.

May 21, 2013
Sponsored Content

Intercell AG / Merger between Intercell and Vivalis planned to complete on May 28, 2013 - Relevant documents filed with the Commercial Court of Lyon

Intercell AG / Merger between Intercell and Vivalis planned to complete on May 28, 2013 - Relevant documents filed with the Commercial Court of Lyon

May 14, 2013

Intercell AG / Yearly Report

Intercell AG / Yearly Report

April 23, 2013
Sponsored Content

Intercell AG / Vivalis SA shareholders approved the proposed merger of equals to create Valneva SE

Intercell AG / Vivalis SA shareholders approved the proposed merger of equals to create Valneva SE

March 7, 2013

Intercell AG announces Q4 and preliminary full year 2012 financial results and business update

Intercell AG announces Q4 and preliminary full year 2012 financial results and business update

March 5, 2013

Intercell AG / Intercell announces pediatric approval of its Japanese Encephalitis vaccine in Europe

Intercell AG / Intercell announces pediatric approval of its Japanese Encephalitis vaccine in Europe

February 12, 2013

Intercell AG / Intercell and Vivalis provide update on the progress towards intended merger

Intercell AG / Intercell and Vivalis provide update on the progress towards intended merger

January 28, 2013

Intercell receives CHMP positive opinion for the pediatric indication of its Japanese Encephalitis vaccine in Europe

Intercell receives CHMP positive opinion for the pediatric indication of its Japanese Encephalitis vaccine in Europe

December 19, 2012
Sponsored Content

Intercell AG announces Q3 2012 financial results and provides operational update

Intercell AG announces Q3 2012 financial results and provides operational update

November 7, 2012

Intercell AG provides update on IXIARO®/JESPECT® sales growth and expected full year financial performance

Intercell AG provides update on IXIARO®/JESPECT® sales growth and expected full year financial performance

October 16, 2012

Vienna Stock Exchange: Winners and Losers (2012-06-02)

Daily News Flash from the Vienna Stock Exchange: Upgrades and Downgrades, Analyzes and Comments.

June 2, 2012

Intercell Completes Equity Private Placement

The Austrian pharmaceutical company raises funds of € 15.2m at a price of € 2.30 per new share - bringing total volume of combined debt and equity financing to € 35.2m.

May 15, 2012

Intercell Remains in the Loss Area

The Austrian pharmaceutical company recorded a net loss of € 8.1m in the first quarter of 2012 after € 11.3m in the first quarter of 2011.

May 8, 2012
Sponsored Content

Vienna Stock Exchange: Winners and Losers (2012-05-07)

Daily News-Flash from Vienna Stock Exchange: Upgrades and Downgrades, Winners and Losers.

May 7, 2012 · Updated: May 7, 2012; 18:33

Vienna Stock Exchange: Winners and Losers (2012-04-27)

Daily News-Flash from Vienna Stock Exchange: Upgrades and Downgrades, Winners and Losers.

April 27, 2012

Vienna Stock Exchange: Winners and Losers (2012-03-07)

Daily News Flash from Vienna Stock Exchange. Upgrades and Downgrades, Winners and Losers.

March 7, 2012 · Updated: March 7, 2012; 19:41

Intercell Does Not Leave the Loss zone

The Austrian pharmaceutical company announces preliminary full year 2011 financial results. Losses totaled € 29m.

March 6, 2012

Vienna Stock Exchange: Winners and Losers (2012-02-25)

Daily News-Flash from Vienna Stock Exchange: Upgrades and Downgrades, Winners and Losers.

February 25, 2012
Sponsored Content

Intercell Plans to Achieve Turnaround in 2014

The Vienna-listed pharmaceutical company Intercell expects to return to the profit zone in 2014.

February 6, 2012

Vienna Stock Exchange: Winners and Losers (2012-01-18)

Daily News-Flash from the Vienna Stock Exchange: Upgrades and Downgrades, Winners & Losers.

January 18, 2012 · Updated: January 18, 2012; 17:58

Vienna Stock Exchange: Winners and Losers (2012-01-16)

Daily News-Flash from Vienna Stock Exchange: Upgrades and Downgrades, Winners and Losers.

January 16, 2012

New Chairman for Intercell’s Supervisory Board

Thomas Szucs succeeds Michael Gréco who remains on the Supervisory Board of the Austrian pharmaceutical company.

December 30, 2011

Vienna Stock Exchange: Winners and Losers (2011-12-10)

Daily News-Flash from the Vienna Stock Exchange: Upgrades & Downgrades, Winners & Losers.

December 10, 2011
Sponsored Content

Vienna Stock Exchange: Winners and Losers (2011-12-09)

Daily News-Flash from the Vienna Stock Exchange: Upgrades & Downgrades, Winners & Losers.

December 9, 2011 · Updated: December 9, 2011; 18:00

Vienna Stock Exchange: Winners and Losers (2011-12-08)

Daily News-Flash from the Vienna Stock Exchange. Upgrades & Downgrades, Winners & Losers.

December 8, 2011

Vienna Stock Exchange: Winners and Losers (2011-11-16)

Daily News-Flash from the Vienna Stock Exchange. Upgrades & Downgrades, Winners & Losers.

November 16, 2011

Intercell Receives Approval for Vaccine in India

The Austrian pharmaceutical company achieved an important milestone in the roll-out of its Japanese Encephalitis vaccine in endemic countries.

November 10, 2011

Intercell Still Reports Losses

The Austrian pharmaceutical company could reduce its net losses from € 50.8m to € 20.62m. For the full year the net loss expectations ranges up to € 40m.

November 8, 2011
Sponsored Content

Vienna Stock Exchange: Winners and Losers (2011-11-02)

Daily News-Flash from the Vienna Stock Exchange: Upgrades and Downgrades, Winners and Losers.

November 2, 2011

R&D Expenses on the Rise

The largest Austrian Enterprises increased their budgets for research & development by 9.6% on average. This is slightly beyond the global average (9.3%).

October 24, 2011

Intercell Continues Development of Vaccines

The Austrian pharmaceutical company announces first data from its Phase I clinical trial with vaccine candidate to prevent Clostridium difficile infections.

October 24, 2011

29 Austrian Companies Ranked in "EU Industrial R&D Investment Scoreboard"

Benteler International, Voestalpine, Borealis, Intercell, Zumtobel are the first five Austrian firms in the “EU Industrial R&D Investment Scoreboard”. The ranking was prepared by the European Commission.

October 19, 2011

Intercell: EU Invests € 30m in Research Program

The Austrian pharmaceutical company will receive co-funding for a collaborative research project from the European Union.

September 29, 2011
Sponsored Content

Intercell Looking for Private Equity Shareholder

According to Bloomberg, the Austrian pharmaceutical company negotiates with potential investors in order to strengthen the equity base.

September 27, 2011

Intercell Successfully Completes Vaccine Study in India

The Austrian biotech company achieved an important step in the licensure process of a vaccine for children.

September 16, 2011

Vienna Stock Exchange: Winners and Losers (2011-09-07)

Daily News-Flash from the Vienna Stock Exchange: Upgrades and Downgrades, Winners and Losers.

September 7, 2011

Vienna Stock Exchange: Winners and Losers (2011-08-18)

Daily News-Flash from the Vienna Stock Exchange: Upgrades & Downgrades, Winners & Losers.

August 18, 2011

Intercell: Restructuring Is Progressing

Sales of the company’s only product on the market increased by 85% in the first six months of the year. Net loss was down 44.2%.

August 16, 2011
Sponsored Content

Intercell Is Looking for Financial Investors

The ailing Austrian biotech company is in urgent need of cash. An acquisition, strategic partnerships and a capital increase are being evaluated.

July 19, 2011

Vienna Stock Exchange: Winners and Losers (2011-06-30)

Daily News-Flash from the Vienna Stock Exchange: Upgrades & Downgrades, Winners & Losers.

June 30, 2011

Vienna Stock Exchange: Winners and Losers (2011-06-24)

Daily News-Flash from the Vienna Stock Exchange: Upgrades & Downgrades, Winners & Losers.

June 24, 2011

Intercell: “We Will Stabilize Our Share Price”

The Austrian biotech company recorded a dramatic drop in its share price. The CEO remains optimistic and promises stabilization.

June 21, 2011

Vienna Stock Exchange: Winners and Losers (2011-06-15)

Daily News-Flash from the Vienna Stock Exchange: Upgrades & Downgrades, Winners & Losers.

June 15, 2011

Vienna Stock Exchange: Winners and Losers (2011-06-14)

Daily News-Flash from the Vienna Stock Exchange: Upgrades & Downgrades, Winners & Losers.

June 14, 2011

Vienna Stock Exchange: Winners and Losers (2011-06-10)

Daily News-Flash from the Vienna Stock Exchange: Upgrades & Downgrades, Winners & Losers.

June 10, 2011

Vienna Stock Exchange: Winners and Losers (2011-06-09)

Daily News-Flash from the Vienna Stock Exchange: Upgrades & Downgrades, Winners & Losers.

June 9, 2011

Vienna Stock Exchange: Winners and Losers (2011-06-08)

Daily News-Flash from the Vienna Stock Exchange: Upgrades & Downgrades, Winners & Losers.

June 8, 2011

Intercell to Cut Jobs and Research Budget

The share price plunged by more than 30% after the Austrian pharmaceutical company had announced the termination of a vaccine study.

June 8, 2011

Vienna Stock Exchange: Winners and Losers (2011-05-23)

Daily News-Flash from the Vienna Stock Exchange: Upgrades & Downgrades, Winners & Losers.

May 23, 2011
1
2
3
next ›
Sponsored Content
Fast News Search
Featured
See latest Vindobona Newsletter
Sign up now for full site access and to read a limited amount of free premium articles per month:
Sign Up
×
Sponsored Content
Sponsored Content
©1995-2023 Vindobona
Contact
Help
Imprint
Press
Careers
Partners
Terms & Conditions
Site Security
Privacy
Sitemap
Advertise
About Us